Next we compared the anti-NSCLC activity of GDC-0349 with other known Akt-mTOR inhibitors, including the mTORC1 inhibitor rapamycin, the Akt specific inhibitor perifosine28,29 and mTOR kinase inhibitor AZD-201430. Here, MTOR is linked to non-small cell lung carcinoma.